Pfizer Unveils New San Francisco-Based Biotech Center, R&D Leaders
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm names Global R&D-VP Martin Mackay to succeed LaMattina, taps former Merck exec to head clinical development.